MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAHS Cancer Control Alberta

About this trial

Cancers are often treated with external beam radiotherapy. Current radiotherapy treatments are performed using computed tomography (also known as CT) scans which may not always clearly identify the cancer. In some instances, magnetic resonance imaging (MRI) may be able to better identify cancers. Therefore, efforts are currently underway to use the MRI scans to improve radiotherapy treatments or eventually even use radiotherapy equipment that only uses MRI scans to guide treatments. This new technology that will only use MRI scans to guide treatments is called the Linac-MR (linear accelerator with an MRI). The purpose of this pilot phase of the study is to test whether the Alberta linac-MR P3 system at the Cross Cancer Institute can acquire high quality MR images safely. It will allow the researchers to develop the best collection of MR images possible with this new machine, in order to allow them to visualize tumors for future patients that are treated on this machine.

Eligibility criteria

Qualifiers

Adults ≥ 18 years of age

Patients deemed fit to undergo high dose external beam radiation therapy by their attending radiation oncologist

Disqualifiers

Patients with contraindications for MRI

Patients who are unable to lie flat and still for the duration of the expected scan acquisition

Patients who are unable to provide informed consent

Trial design

Treatments tested in this trial

  • MR scan with the Alberta linac-MR P3 system

Treatment groups

250 Participants
are divided into 1 treatment group

Sponsors and collaborators